Is Axsome Therapeutics, Inc. (AXSM) a Buy, Sell, or Hold?
Axsome Therapeutics, Inc.
NASDAQ:AXSM
$235.26 USD
$6.98 (3.06%)
- Volume
- 482.76K
- Average Volume
- 923.51K
- Market Capitalization
- $12.11B
- P/E Ratio
- -63.07
- Dividend Yield
- 0.00%
- Price Target
- $259.50
- Year High
- $260.19
- Year Low
- $96.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.39
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-9.3% DOWNSIDE
$259.50 Price Target
UPSIDE/DOWNSIDE HIGH
-38.1% DOWNSIDE
$380.00 Price Target High
UPSIDE/DOWNSIDE LOW
17.6% UPSIDE
$200.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Leonid Timashev | $304 | $242.6 | 2026-07-07 07:29 AM | 25.3% |
| Jefferies | Andrew Tsai | $380 | $246.34 | 2026-06-11 05:34 AM | 54.3% |
| Deutsche Bank | David Hoang | $280 | $230.1 | 2026-05-05 08:49 AM | 21.7% |
| RBC Capital | Leonid Timashev | $302 | $231 | 2026-05-05 08:17 AM | 30.7% |
| Robert W. Baird | Brian Skorney | $246 | $223.7 | 2026-05-05 06:25 AM | 10.0% |
| Guggenheim | Yatin Suneja | $260 | $227.31 | 2026-05-04 01:19 PM | 14.4% |